As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

Digitoxin in addition to guideline-directed medical therapy, reduced the risk of a composite of all-cause death and hospitalization for worsening heart failure (HF) among patients with advanced HF and ...

Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...

Jorge. E Romero, MD, FHRS, FACC is Director of the Arrhythmia and Electrophysiology Research Program and Associate Director of the Ventricular Arrhythmia Program at Brigham and Women's Hospital. He is ...

Mavacamten did not significantly improve exercise capacity as assessed by peak oxygen uptake or improve patient-reported health status compared with placebo in patients with symptomatic nonobstructive ...

Our records indicate that the Ovid subscription has been in our system for over a year. Please contact your administrator or librarian to make sure the institutional subscription to Cardiosource Plus ...

Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, ...

Centers for Disease Control and Prevention (CDC) data shows an alarming increase in obesity among the United States (US) population, from 30.5% in 2000 to 42.4% in 2018. The combination of overweight ...

Completing (or Continuing) Your Training? Let's Stay in Touch! During and just after your training, the right support is critical. Ensure we're providing you with support tailored to your needs. If ...

"Who I am NOT has captured a lot of people's attention. So, who am I? I am Cathie Biga, a leader, health care administrator, nurse, executive, mom, wife, nana and I still think of myself as a ...

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. The updated ASCVD Risk Estimator Plus uses up-to-date ACC clinical policy and user ...